Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Novartis researchers are using data to accelerate drug development.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Deep in a forest in the West African country of Ghana, two men are searching for plants that they hope could ultimately provide a cure for some of the world’s deadliest diseases.

Novartis opens up a path of research to protect proteins that guard against cancer.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.